Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins attending: chief complaint: transferred from hospital in ny for treatment of tracheoesophageal fistula major surgical or invasive procedure: 1. rigid bronchoscopy at the yellow dumon bronchoscope, flexible bronchoscopy with therapeutic aspiration, bronchoalveolar lavage of the left lower lobe, balloon dilatation, left main stem, stent placement. ultraflex 40 x 14 covered stent, left main stem, silicone y-stent placement. flexible bronchoscopy, stent revision, therapeutic aspiration of secretions thoracentesis under thoracic ultrasound. flexible bronchoscopy, therapeutic aspiration of secretions. placement of a-line, cvl r ij (both removed) history of present illness: the patient is a 76 yo non-smoker with nsclca, dx'd 1 year ago s/p chemo/xrt, believed to be in remission who was for a tia who was found to have a tracheo-esophageal fistula (large defect in esophagus, two small defects in distal trachea lateral to lms and carina) who underwent esophageal stent 1 wk ago but remained intubated on vent with difficult weaning. bronch one week ago demonstrated erosion of stent thru posterior tracheal membrane. the patient was transferred per the family's request for further management of the tef. past medical history: htn, afib nsclca: originally treated with tarceva only, then lad progressed and treated with chemo/xrt. lul opacity developed after xrt and attributed to post rad changes (per son) - pet negative and has subsequently decreased in size, vertigo, h/o hemoptysis while ac, b tkr, ccy, breast ca s/p lumpectomy social history: strong family support, married with two sons family history: noncontributory physical exam: upon discharge: nad a and ox3 perrl, dry mucus membranes, no jvd, r cvl dressing ij in place irreg irreg ? sys murmur at ursb coarse bs at bases b/l soft nt/nd foley in place no c/c slight edema le 2+ dp b/l l picc ue r arm severe ecchymoses pertinent results: 02:42am blood wbc-5.9 rbc-2.70* hgb-7.9* hct-23.8* mcv-88 mch-29.2 mchc-33.1 rdw-19.6* plt ct-118* 11:09am blood wbc-7.0 rbc-2.94* hgb-8.8* hct-26.6* mcv-90 mch-29.9 mchc-33.1 rdw-20.6* plt ct-95* 02:42am blood plt ct-118* 11:09am blood pt-12.7 ptt-53.3* inr(pt)-1.1 02:42am blood glucose-148* urean-22* creat-0.4 na-136 k-3.5 cl-99 hco3-29 angap-12 11:09am blood glucose-81 urean-47* creat-0.7 na-145 k-4.4 cl-109* hco3-29 angap-11 02:27am blood alt-31 ast-18 ld(ldh)-402* alkphos-118* totbili-0.6 02:42am blood calcium-7.9* phos-3.3 mg-1.7 11:09am blood albumin-2.9* calcium-7.9* phos-4.2 mg-2.1 02:41am blood vanco-12.3 11:49am blood type-art po2-106* pco2-31* ph-7.56* caltco2-29 base xs-6 11:17am blood type-art po2-213* pco2-48* ph-7.39 caltco2-30 base xs-3 brief hospital course: procedures during admission 1. rigid bronchoscopy at the yellow dumon bronchoscope, flexible bronchoscopy with therapeutic aspiration, bronchoalveolar lavage of the left lower lobe, balloon dilatation, left main stem, stent placement. ultraflex 40 x 14 covered stent, left main stem, silicone y-stent placement. flexible bronchoscopy, stent revision, therapeutic aspiration of secretions thoracentesis under thoracic ultrasound. flexible bronchoscopy, therapeutic aspiration of secretions. placement of a-line, cvl r ij # tracheoesophageal fistula the patient was transferred intubated from hospital in ny on for stent revision to a tracheo-esophageal fistula. on she underwent a ct scan that revealed collapse of the left lung with partial sparing of the lingula. left main bronchus stent was seen in place and was patent, although there was diffuse attenuation of the airways distal to the stent on the left, with moderate pleural effusions b/l. that day she underwent rigid and flexible bronchoscopy with therapeutic aspiration, bal of left lower lobe, balloon dilatation, left main stem ultraflex 40 x 14 covered stent, and left main stem silicone y-stent placement. the patient tolerated the procedure well, although she remained with copious secretions, and so underwent stent revision on and again on . on she was extubated, which she tolerated well although with need for frequent suctioning, chest pt, and required therapeutic bronchoscopy for secretions on . she was also maintained on scheduled nebulizers and prednisone. on she underwent a barium swallow to assess for the tef, but the patient was unable to complete the study as she aspirated the barium during the study. however, contrast was seen within the left main stem bronchus and distal airways, most likely reflecting aspiration although without lateral views, persistent tracheoesophageal fistula could not be excluded. on she had a follow up cxr that revealed: the stent, central venous access line, and abdominal drain are in unchanged position. the right-sided basal consolidation has decreased in extent. the left retrocardiac atelectasis is unchanged. also unchanged is still moderate cardiomegaly. unchanged mediastinal widening and increase in mediastinal diameter. no newly occurred focal parenchymal opacities. # ventilator associated pneumonia the bal on revealed mrsa > 100k, and so the patient was started on iv vancomycin for a total therapy duration of two weeks. she remained afebrile and hemodynamically stable throughout her stay. #pleural effusion on the patient underwent thoracentesis given radiologic and clinic findings that was transudative in nature, with glucose 214, ldh 170, and total protein of 2.5. she was also started on lasix for diuresis. # hypertension the patient's hypertension was eventually controlled through a combination of clonidine patch, enalapril, labetolol, and metoprolol. # atrial fibrillation the patient has a history of atrial fibrillation and was initially placed on iv diltiazem and esmolol for rate control, which was then converted to po meds via the peg; however, her rate was not controlled until she was digoxin loaded on and her rate slowed from af in the 120s to the 80s. she was then placed on her home dose of digoxin 0.125 mg/day, which controlled her rate throughout her stay. # atrial thrombus the ct on revealed a filling defect along posterosuperior wall of left atrium could represent direct extension of tumor or intraluminal thrombus. given this finding in the presence of atrial fibrillation, she underwent an echocardiogram that revealed a possible 1.1cm mass in the body of la,mild-moderate mitral regurgitation, mild pulmonary artery systolic hypertension, mild symmetric left ventricular hypertrophy, but normal cavity size and global systolic function (lvef>55%). she was then placed on therapeutic lovenox for the fibrillation and the thrombus, and given her history of a tia, even though she is at a risk for falls. # dysphagia the patient had a peg tube placed by ir on given that she was intubated for feeding. she was started on tube feeds , which she tolerated, and she was kept npo given that she aspirated during her barium swallow. # c difficile the patient was transferred from with a history of c difficile diarrhea, and so she was kept on her po vancomycin. # anemia the patient was admitted from with anemia (hct 26.6), which has slowly trended down to 23.8, likely secondary to phlebotomy. this should be followed in the future, and her baseline anemia is of unknown etiology. medications on admission: catapres tts qwed, nexium 40 qday, solumedrol 10 qday, reglan 10 q6, enalapril 1.35 q4, haldol 1 q4prn, vanc 250 q6, xopenex discharge medications: 1. bisacodyl 5 mg tablet, delayed release (e.c.) : two (2) tablet, delayed release (e.c.) po daily (daily) as needed. 2. vancomycin 250 mg capsule : one (1) capsule po q6h (every 6 hours). 3. nystatin-triamcinolone 100,000-0.1 unit/g-% ointment : one (1) appl topical (2 times a day) as needed. 4. docusate sodium 50 mg/5 ml liquid : one (1) po bid (2 times a day): hold for loose stool. 5. senna 8.6 mg tablet : one (1) tablet po bid (2 times a day): hold for loose stool. 6. metoprolol tartrate 50 mg tablet : two (2) tablet po tid (3 times a day): hold for sbp < 110, hr < 60. 7. insulin regular human 100 unit/ml solution : one (1) injection asdir (as directed). 8. acetylcysteine 20 % (200 mg/ml) solution : one (1) ml miscellaneous q6h (every 6 hours). 9. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization : one (1) inhalation q6h (every 6 hours). 10. guaifenesin 100 mg/5 ml syrup : 5-10 mls po bid (2 times a day). 11. metoclopramide 10 mg tablet : one (1) tablet po q6h (every 6 hours). 12. lansoprazole 30 mg tablet,rapid dissolve, dr : one (1) tablet,rapid dissolve, dr daily (daily). 13. prednisone 20 mg tablet : one (1) tablet po daily (daily). 14. diltiazem hcl 90 mg tablet : one (1) tablet po qid (4 times a day) as needed for atrial fibrillation: hold for hr < 60, sbp < 110. 15. enoxaparin 80 mg/0.8 ml syringe : one (1) subcutaneous q12h (every 12 hours). 16. furosemide 40 mg tablet : one (1) tablet po tid (3 times a day): decrease pending creatinine levels. 17. enalapril maleate 10 mg tablet : four (4) tablet po daily (daily) as needed for htn: hold for sbp <110. 18. clonidine 0.3 mg/24 hr patch weekly : one (1) patch weekly transdermal qwed (every wednesday). 19. hydrochlorothiazide 12.5 mg capsule : one (1) capsule po daily (daily): hold for sbp < 110. 20. dextromethorphan-guaifenesin 10-100 mg/5 ml syrup : five (5) ml po bid (2 times a day). 21. digoxin 250 mcg/ml solution : one (1) injection daily (daily). 22. labetalol 100 mg tablet : one (1) tablet po tid (3 times a day): hold for sbp < 110, hr < 60. 23. sodium chloride 0.9% flush 10 ml iv prn line flush temporary central access-icu: flush with 10ml normal saline daily and prn. 24. vancomycin in dextrose 1 gram/200 ml piggyback : one (1) intravenous q 24h (every 24 hours) for 7 days: last day . discharge disposition: extended care facility: discharge diagnosis: tracheo-esophageal fistula, htn, atrial fibrillation, atrial thrombus, dysphagia pmx: non-small cell lung cancer s/p chemo, xrt, atrial fibrillation, htn, vertigo, h/o hemoptysis while ac, b tkr, ccy, breast ca s/p lumpectomy discharge condition: stable discharge instructions: 1. give medicines as prescribed (through the j tube unless otherwise specified); adjust 2. q2 hour chest pt and suction 3. oxygen therapy to maintain saturations 90-95% 4. physical therapy 5. check cbc, electrolytes once weekly; transfuse as needed 6. check digoxin level in one week followup instructions: 1. follow-up with dr ; call office for appointment 2. follow up with your primary care physician 3. reconsider your lovenox therapy in future as determined by safety given your atrial thrombus but also your fall risk md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours parenteral infusion of concentrated nutritional substances fiber-optic bronchoscopy enteral infusion of concentrated nutritional substances thoracentesis other bronchoscopy other lavage of bronchus and trachea non-invasive mechanical ventilation percutaneous [endoscopic] gastrostomy [peg] other intubation of respiratory tract other intubation of respiratory tract other intubation of respiratory tract bronchial dilation diagnoses: anemia, unspecified mitral valve disorders unspecified pleural effusion atrial fibrillation personal history of malignant neoplasm of breast atrial flutter pulmonary collapse acute respiratory failure malignant neoplasm of bronchus and lung, unspecified intestinal infection due to clostridium difficile long-term (current) use of anticoagulants mechanical complication due to other implant and internal device, not elsewhere classified carrier or suspected carrier of methicillin resistant staphylococcus aureus surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation ventilator associated pneumonia personal history of antineoplastic chemotherapy personal history of irradiation, presenting hazards to health other abnormal glucose tracheoesophageal fistula other specified disorders of esophagus other diseases of trachea and bronchus benign essential hypertension methicillin resistant pneumonia due to staphylococcus aureus dysphagia, pharyngoesophageal phase 

Answer: The patient is high likely exposed to